Clinical Trial Update: Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing rivaroxaban and aspirin in patients with CHD and GD undergoing PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Rivaroxaban | Phase 4 | Status: UNKNOWN